mitogen-induced transformation and the production of reactive oxidants by mononuclear leucocytes ( mnls ) from patients with chronic dermatological disorders were investigated in vitro before and during the administration of the antimycobacterial/immunosuppressive agent clofazimine ( 200 mg 3 times weekly ) .
C0360390
antimycobacterial
C0008996
clofazimine